Fig. 1From: Marked improvement of neuropsychiatric symptoms following control of allergy symptoms with the use of humanized murine anti-IgE antibody (omalizumab) in 2 patients with severely limited expressive languageAberrant Behavior Checklist (ABC) subscale scores before and after the omalizmab treatment in the case #1Back to article page